Robert Dwyer Nolan
Direktor/Vorstandsmitglied bei Phico Therapeutics Ltd.
Profil
Robert Dwyer Nolan is the founder of Cardiff Biologicals Ltd.
He is currently a Non-Executive Director at Phico Therapeutics Ltd.
He was previously the Chairman of Cardiff Protides Ltd.
and held various Director positions at AstraZeneca PLC, Genedrive Plc, Epistem Ltd., NeuTec Pharma Ltd., and F2G Ltd.
He earned a doctorate degree from King's College London.
Aktive Positionen von Robert Dwyer Nolan
Unternehmen | Position | Beginn |
---|---|---|
Phico Therapeutics Ltd.
Phico Therapeutics Ltd. Miscellaneous Commercial ServicesCommercial Services Phico Therapeutics Ltd. develops antibiotic bacteria resistant technology. Its products include SASPject PT1.2 used for intra-nasal decolonization, SASPject PT3.1 used for intra-abdominal infections and SASPject PT4 used for both the infections. The company was founded by Dr. Heather Fairhead and is headquartered in Cambridge, the United Kingdom. | Direktor/Vorstandsmitglied | - |
Ehemalige bekannte Positionen von Robert Dwyer Nolan
Unternehmen | Position | Ende |
---|---|---|
GENEDRIVE PLC | Direktor/Vorstandsmitglied | 31.12.2018 |
Epistem Ltd.
Epistem Ltd. BiotechnologyHealth Technology Epistem Ltd. engages in the provision of research solutions. It offers laser capture microdissection, imaging; microbiome, gene expression, NGS, DNA genotyping, and plucked hair analysis; Histology and IHC, and analytical services. The company was founded by Christopher Stanislaus Potten, Catherine Booth and Julie Tudor in 2000 and is headquartered in Manchester, the United Kingdom. | Direktor/Vorstandsmitglied | 01.10.2008 |
ASTRAZENECA PLC | Corporate Officer/Principal | 01.01.2004 |
Cardiff Biologicals Ltd. | Gründer | - |
F2G Ltd.
F2G Ltd. Pharmaceuticals: MajorHealth Technology F2G Ltd. provides novel drugs for the treatment of life-threatening systemic fungal diseases. It primarily focuses on developing an F3 series of anti mould compound, which is an antifungal agent that acts through a mechanism different from marketed drugs. The company was founded in 1998 and is headquartered in Manchester, the United Kingdom. | Direktor/Vorstandsmitglied | - |
Ausbildung von Robert Dwyer Nolan
King's College London | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Börsennotierte Unternehmen | 2 |
---|---|
GENEDRIVE PLC | Health Technology |
ASTRAZENECA PLC | Health Technology |
Private Unternehmen | 6 |
---|---|
NeuTec Pharma Ltd.
NeuTec Pharma Ltd. BiotechnologyHealth Technology NeuTec Pharma Ltd. develops biopharmaceutical products. It specializes in the development of genetically recombinant antibodies, or “grabs”, for the treatment of life-threatening infections. The firm's products include Mycograb and Aurograb. The company was founded in 1997 and is headquartered in Camberley, the United Kingdom. | Health Technology |
Phico Therapeutics Ltd.
Phico Therapeutics Ltd. Miscellaneous Commercial ServicesCommercial Services Phico Therapeutics Ltd. develops antibiotic bacteria resistant technology. Its products include SASPject PT1.2 used for intra-nasal decolonization, SASPject PT3.1 used for intra-abdominal infections and SASPject PT4 used for both the infections. The company was founded by Dr. Heather Fairhead and is headquartered in Cambridge, the United Kingdom. | Commercial Services |
Cardiff Protides Ltd. | Commercial Services |
F2G Ltd.
F2G Ltd. Pharmaceuticals: MajorHealth Technology F2G Ltd. provides novel drugs for the treatment of life-threatening systemic fungal diseases. It primarily focuses on developing an F3 series of anti mould compound, which is an antifungal agent that acts through a mechanism different from marketed drugs. The company was founded in 1998 and is headquartered in Manchester, the United Kingdom. | Health Technology |
Cardiff Biologicals Ltd. | Commercial Services |
Epistem Ltd.
Epistem Ltd. BiotechnologyHealth Technology Epistem Ltd. engages in the provision of research solutions. It offers laser capture microdissection, imaging; microbiome, gene expression, NGS, DNA genotyping, and plucked hair analysis; Histology and IHC, and analytical services. The company was founded by Christopher Stanislaus Potten, Catherine Booth and Julie Tudor in 2000 and is headquartered in Manchester, the United Kingdom. | Health Technology |